Anfoe 4000IU Injection (Recombinant Human Erythropoietin Alfa 4000IU)

Introduction:

Anfoe 4000IU Injection contains the active constituent Recombinant Human Erythropoietin Alfa. It stimulates the production of red blood cells (red blood cells carry the hemoglobin, a substance which transports oxygen) in the bone marrow. It is used to treat anemia in kidney disease patients, moderately anemic adults about to have surgery, adults with bone marrow disorder, and patients receiving chemotherapy for solid tumors.

It must not be given to patients with uncontrolled blood pressure and premature infants. There is a chance of increasing the risk of blood clots on the administration of Anfoe 4000IU Injection. Inform your doctor if you know you suffer from or suffered from seizures, liver disease, high blood pressure, anemia, porphyria (a rare blood disorder), and cancer. Inform your doctor if you are planning to get pregnant or pregnant.

Uses of Anfoe 4000IU Injection:

It is used to treat anemia in patients:

• With kidney disease
• Receiving chemotherapy for solid tumors
• With bone marrow disorder
• Who are moderately anemic and about to have surgery

How Anfoe 4000IU Injection works:

It works by stimulating the bone marrow to produce more number of blood cells to treat anemia.

Interactions with other drugs:

Inform your doctor about any medications you are taking or have taken before the treatment.

More information:

Store in refrigerator at 2° C – 8° C. Do not freeze or shake